Invention Grant
- Patent Title: Non-invasive biomarker to identify subject at risk of preterm delivery
-
Application No.: US15708582Application Date: 2017-09-19
-
Publication No.: US10408838B2Publication Date: 2019-09-10
- Inventor: Louis Ragolia
- Applicant: NYU Winthrop Hospital
- Applicant Address: US NY Mineola
- Assignee: NYU Winthrop Hospital
- Current Assignee: NYU Winthrop Hospital
- Current Assignee Address: US NY Mineola
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: G01N33/573
- IPC: G01N33/573 ; A61K31/5575 ; A61K31/195 ; G01N33/68 ; A61K45/06 ; A61K31/137 ; A61K31/454 ; A61K31/44 ; A61K31/4166
Abstract:
Methods for diagnosis to allow prediction of the likelihood of preterm birth based upon the concentration of lipocalin-type prostaglandin D2 synthase (L-PGDS) in cervical vaginal secretions. In addition, specific prostaglandin D2 receptor antagonists may represent novel tocolytic therapeutics.
Public/Granted literature
- US20180003713A1 NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECT AT RISK OF PRETERM DELIVERY Public/Granted day:2018-01-04
Information query
IPC分类:
